These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3460984)

  • 61. Pharmacokinetic profile of meropenem, administered at 500 milligrams every 8 hours, in plasma and cantharidin-induced skin blister fluid.
    Maglio D; Teng R; Thyrum PT; Nightingale CH; Nicolau DP
    Antimicrob Agents Chemother; 2003 May; 47(5):1771-3. PubMed ID: 12709358
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human plasma and skin blister fluid levels of griseofulvin following a single oral dose.
    Schäfer-Korting M; Korting HC; Mutschler E
    Eur J Clin Pharmacol; 1985; 29(1):109-13. PubMed ID: 4054199
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics and tissue penetration of cefepime.
    Nye KJ; Shi YG; Andrews JM; Wise R
    J Antimicrob Chemother; 1989 Jul; 24(1):23-8. PubMed ID: 2777727
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dose linearity and other pharmacokinetics of ofloxacin: a new, broad-spectrum antimicrobial agent.
    Verho M; Malerczyk V; Dagrosa E; Korn A
    Pharmatherapeutica; 1985; 4(6):376-82. PubMed ID: 3866256
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam.
    McNulty CA; Garden GM; Ashby J; Wise R
    Antimicrob Agents Chemother; 1985 Sep; 28(3):425-7. PubMed ID: 4073864
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Skin immunoglobulin deposition following intravenous immunoglobulin therapy in toxic epidermal necrolysis.
    Paquet P; Kaveri S; Jacob E; Pirson J; Quatresooz P; Piérard GE
    Exp Dermatol; 2006 May; 15(5):381-6. PubMed ID: 16630079
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics and tissue penetration of ceftibuten.
    Wise R; Nye K; O'Neill P; Wostenholme M; Andrews JM
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1053-5. PubMed ID: 2393265
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Absorption of bacampicillin and ampicillin and penetration into body fluids (skin blister fluid, saliva, tears) in healthy volunteers.
    Simon C; Malerczyk V; Klaus M
    Scand J Infect Dis Suppl; 1978; (14):228-32. PubMed ID: 279976
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparative pharmacokinetics of ciprofloxacin and ofloxacin in cystic fibrosis patients.
    Pedersen SS; Jensen T; Hvidberg EF
    J Antimicrob Chemother; 1987 Oct; 20(4):575-83. PubMed ID: 3479419
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Tissue penetration of ciprofloxacin after single and multiple doses.
    LeBel M; Vallée F; Bergeron MG
    Antimicrob Agents Chemother; 1986 Mar; 29(3):501-5. PubMed ID: 2940974
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Diffusion of an orally administered single dose of ofloxacin into human bronchial mucus].
    Morel C; Malbruny B; Vergnaud M; Benard Y; Monrocq N
    Pathol Biol (Paris); 1986 May; 34(5):353-6. PubMed ID: 3534705
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The pharmacokinetics and tissue penetration of norfloxacin.
    Adhami ZN; Wise R; Weston D; Crump B
    J Antimicrob Chemother; 1984 Jan; 13(1):87-92. PubMed ID: 6230344
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ofloxacin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis.
    Chan MK; Chau PY; Chan WW
    Clin Nephrol; 1987 Dec; 28(6):277-80. PubMed ID: 3481692
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pharmacokinetics of ofloxacin and a review of its tissue penetration.
    Wise R; Lockley MR
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():59-64. PubMed ID: 3182463
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.
    Nye K; Shi YG; Andrews JM; Ashby JP; Wise R
    J Antimicrob Chemother; 1989 Sep; 24(3):415-24. PubMed ID: 2808194
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Prostatic tissue and fluid levels of DL-8280].
    Kumon H; Furukawa M; Mizuno A; Miyata K; Akazawa N; Ohmori H; Katayama Y; Akaeda T
    Hinyokika Kiyo; 1984 Sep; 30(9):1297-305. PubMed ID: 6596879
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Clinical pharmacology of ofloxacin: a new chemotherapeutic agent belonging to the gyrase inhibitor group].
    Verho M; Dagrosa EE; Malerczyk V
    Infection; 1986; 14 Suppl 1():S47-53. PubMed ID: 3007366
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extravascular penetration of highly protein-bound flucloxacillin.
    Bergan T; Engeset A; Olszewski W; Ostby N; Solberg R
    Antimicrob Agents Chemother; 1986 Nov; 30(5):729-32. PubMed ID: 3800349
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Further methodological improvement in antibiotic bone concentration measurements: penetration of ofloxacin into bone and cartilage.
    Wittmann DH; Kotthaus E
    Infection; 1986; 14 Suppl 4():S270-3. PubMed ID: 3469160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.